| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $8.3B | $7.5B | $10.2B | $4.1B | $2.9B | $5.1B | $0.9B | $1.1B |
| Net Income | $6.8B | $6.9B | $7.3B | $4.1B | $3.6B | $2.9B | $1.0B | $0.4B |
| EPS (Basic) | $3.31 | $3.38 | $3.61 | $2.10 | $1.82 | $0.00 | $2.00 | $0.88 |
| EPS (Diluted) | $3.30 | $3.37 | $3.60 | $2.10 | $1.81 | $0.00 | $1.99 | $0.88 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $212.7B | $190.1B | $177.5B | $158.9B | $140.9B | $127.7B | $117.7B | $103.7B |
| Current Assets | $13.6B | $12.0B | $15.4B | $13.5B | $9.3B | $7.4B | $7.4B | $6.4B |
| Cash & Equivalents | $2.8B | $1.5B | $2.7B | $1.6B | $0.6B | $1.1B | $0.6B | $0.6B |
| Total Liabilities | $146.2B | $129.3B | $118.5B | $109.5B | $95.2B | $82.8B | — | — |
| Current Liabilities | $22.8B | $25.4B | $28.0B | $26.7B | $17.4B | $15.6B | $13.9B | $17.6B |
| Stockholders' Equity | $54.6B | $50.1B | $47.5B | $39.2B | $37.2B | $36.5B | $37.0B | $34.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $12.5B | $13.3B | $11.3B | $8.3B | $7.6B | $8.0B | $8.2B | $6.6B |
| Investing Cash Flow | $-23.9B | $-22.3B | $-23.5B | $-18.4B | $-13.6B | $-13.7B | $-16.2B | $-10.9B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $13.0B | $7.0B | $12.1B | $12.2B | $5.8B | $6.2B | $3.9B | $7.6B |